Knowledge for Use in Practice

Knowledge for Use in Practice delves deep into medical research, providing practical solutions for pressing health concerns that impact all of society. This conference showcases cutting-edge developments in healthcare, ensuring that scientific breakthroughs are not just theoretical, but applied to create real-world health solutions.

The main sections of Knowledge for Use in Practice conference are highlighted below.

The Role of Dysregulated Immune Responses and Infection in Disease Pathology

26-28 March, Hippocrates Lecture Hall, RSU, 16 Dzirciema iela

26 March. Perspective Strategies to Overcome Antibacterial Resistance and Tackle Hard-to-Treat Infections

As the threat posed by multidrug-resistant pathogens intensifies, we find ourselves at a critical juncture where antibiotic treatment is increasingly ineffective. Phage therapy has emerged as a promising alternative and, in some instances, the only viable option for the patient. Unlike broad-spectrum antibiotics, phages target only specific bacteria, thus not disturbing the microbiota. The abundance of phages and their interaction with bacteria have shown that phages could complement or even replace antibiotics in the fight against infections. The research in phage application in medicine and other spheres is flourishing and has demonstrated immense potential for the future treatment of difficult-to-treat infections.

27 March. Immunology and Neuroimmunology in Research and Clinical Practice 

This section focuses on the comprehensive study of primary immunodeficiencies and autoimmune diseases, with a particular emphasis on neurological autoimmune disorders and their complex underlying pathogenesis. It also delves into the investigation of hereditary angioedema and chronic spontaneous urticaria, two key areas in the study of immunological disorders. Additionally, the section explores various forms of allergies and secondary immunodeficiencies, examining their triggers, mechanisms, and impacts on the immune system. Through a multidisciplinary approach, this research seeks to advance the understanding of these conditions and contribute to the development of innovative diagnostic and therapeutic strategies.

28 March. Infection Associated Non-Communicable Diseases

"Infection associated non-communicable diseases" delves into the critical role of infections in the onset and progression of non-communicable diseases, emphasizing how host-pathogen interactions contribute to autoimmune conditions. Topics will include the latest research on infections as triggers for chronic diseases, the discovery of novel biomarkers, and cutting-edge detection methods. Through these discussions, the section aims to illuminate the connections between infectious processes and long-term health outcomes, driving forward both research and clinical strategies.

Keynote Speakers

Perspective Strategies to Overcome Antibacterial Resistance and Tackle Hard-to-Treat Infections

Prof. Jean Paul Pirnay

Queen Astrid Military Hospital, Belgium

Assist. Prof. Saija Kiljunen

University of Helsinki, Finland

Prof. Krystyna Dabrowska

Wroclaw University of Science and Technology, Poland

Immunology and Neuroimmunology in Research and Clinical Practice

MD, PhD Kai Kisand

Institute of Biomedicine and Translational Medicine, University of Tartu, Estonia

MD, PhD Anna Rostedt Punga

Uppsala University, Sweden

Carina Saggau

University Medical Center Schleswig-Holstein

Prof. Olena Sharikadze

Institute of Postgraduate Education, Shupyk National Healthcare University of Ukraine

Jakob Theorell

The Karolinska Institute, Sweden

Prof. Liis Väli

University of Tartu, Clinic of Neurology

Prof. Anastasiia Bondarenko

European Medical School, International European University, Kyiv, Ukraine

Edita Kuncevičienė

Lithuanian University of Health Sciences, Lithuania

Prof. Aurelija Žvirblienė

Vilnius University, Lithuania

Infection Associated Non-Communicable Diseases

Prof. Javier Ramón Azcón

Institute for Bioengineering of Catalonia, Spain

Scientific Committee

Perspective Strategies to Overcome Antibacterial Resistance and Tackle Hard-to-Treat Infections

• Jean-Paul Pirnay, PhD, Queen Astrid Military Hospital, Head of the Laboratory for Molecular and Cellular Technology, Belgium
• Asst. prof. Saija Kiljunen, PhD, Human Microbiome Research Program, Faculty of Medicine, University of Helsinki PrecisionPhage Ltd, Jyväskylä, Finland
• Prof. Krystyna Dabrowska, PhD, Laboratory of Phage Molecular Biology, Institute of Immunology and Experimental Therapy, Wrocław, Wrocław University of Science and Technology, Faculty of Medicine, Wrocław, Research and Development Center, Regional Specialist Hospital, Wrocław, Poland
• Prof. Juta Kroiča, MD, PhD, Department of Biology and Microbiology, Rīga Stradiņš University
• Prof. Ludmila Vīksna, Md, PhD, Department of Infectology, Rīga Stradiņš University; Riga East University Clinical Hospital
• Asst. Prof. Kārlis Rācenis, MD, PhD, Department of Biology and Microbiology, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital
• Researcher Ņikita Zrelovs, PhD, Department of Biology and Microbiology, Rīga Stradiņš University, Latvian Biomedical Research and Study Centre
• Asst. prof. Monta Madelāne, MD, PhD, Department of Infectology, Rīga Stradiņš University; Department of Infection Control, Riga East University Clinical Hospital

Immunology and neuroimmunology in Research and clinical practice

• Prof. Kai Kisand, Cellular Immunology at the Institute of Biomedicine and Translational Medicine, the University of Tartu, Estonia 
• Prof. Aurelija Žvirbliene, Head of the Department of Immunology and Cell Biology, Institute of Biotechnology of Vilnius University 
• Shahar Shelly,  MD, PhD, Director of Neuromuscular centre, Institute of Pathology, Rambam Medical Center, Haifa, Israel
• Prof. Nataļja Kurjāne, Department of Biology and Microbiology, Rīga Stradiņš University; lead researcher at the Scientific Laboratory of Molecular Genetics, RSU; Head of the Centre of Clinical Immunology and Allergology, Pauls Stradins Clinical University Hospital
• Assoc. Prof. Viktorija Ķēniņa, Department of Biology and Microbiology, Rīga Stradiņš University; lead researcher at the Scientific Laboratory of Molecular Genetics; Head of the Centre of Rare Neurological diseases,  Pauls Stradins Clinical University Hospital
• Dr. med. Zaiga Nora-Krūkle, Director, Institute of Microbiology and Virology, Rīga Stradiņš University

Infection Associated Non-Communicable Diseases

• Dr. med. Zaiga Nora-Krūkle, Director, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Modra Murovska, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Šimons Svirskis, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Alīna Sultanova, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Asst. Prof. Dr. med. Anda Kadiša, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. biol. Irina Holodņuka, Lead Researcher, Institute of Microbiology and Virology, Rīga Stradiņš University
• Dr. med. Bhupesh Kumar Prusty, Tenured Professor, Institute of Microbiology and Virology, Rīga Stradiņš University
• Gilad Halpert, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Israel
• Prof. Dario Di Luca, Dept. Medical Sciences, University of Ferrara, Italy
• Daria Bortolotti, Department of Chemical, Pharmaceutical and Agricultural Science, University of Ferrara, Italy
• Prof. Marion Schneider, Clinic for Anaesthesiology and Intensive Care Medicine, Ulm University Hospital, Germany

Main Topics

• Clinical microbiology 
• Vaccination 
• Antimicrobial resistance 
• Nosocomial infections 
• Treatment methods for hard-to-treat infections 
• Phage therapy 
• Immunology 
• Neuroimmunology 
• Host-pathogen interaction 
• Infections in the development of non-communicable diseases 
• Autoimmunity

Treatment and Quality Improvement in Healthcare

26–28 March, Auditorium #3, RSU, 16 Dzirciema iela

26 March. Oncology and Hematology – Biomarker-Driven Precision Medicine

In the session distinguished international faculty and local cancer experts/researchers will present the results of their latest studies. Mirjam Blattner-Johnson will give an update in the advances in pediatric brain tumor research. Prof. Jacek Gronwald and Prof. Arcangela De Nicolo will uncover cutting edge studies on BRCA1/2 carriers – both clinical and molecular aspects in prevention and management of cancer. The topics in personalized cancer medicine and biomarkers research will include genetic population screening of hereditary breast and ovarian cancer, epidemiology and phenotype/genotype correlations of breast and ovarian cancer predisposition genes, as well as microbiome studies during the cancer treatment.

27 March. Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond

This session will explore the comprehensive utility of kidney disease registries in understanding disease progression, optimizing treatment responses, and assessing cost-effectiveness in chronic kidney disease (CKD) management. Discussions will delve into cutting-edge research on IgA nephropathy (IgAN) pathogenesis, highlighting the pivotal roles of B cells and other biomarkers. The use of renal biopsy registries for detailed analysis of IgAN progression will be examined, alongside strategies for effective disease surveillance and quality control in chronic conditions. Attendees will gain a comprehensive understanding of how registry data can drive advancements in both scientific research and clinical practice.

28 March. Rare Diseases

The Rare Disease Session will address the current challenges and advancements in rare disease research and management both in Latvia and globally. The session will conclude with a clinically focused discussion on selected rare disease case reports, providing practical insights for healthcare professionals.

Keynote Speakers

Oncology and Hematology – Biomarker-Driven Precision Medicine

Mirjam Blattner-Johnson

Hopp Children's Cancer Center Heidelberg, Germany

MD, PhD Arcangela De Nicolo

Institute of Oncology and Molecular Genetics, Rīga Stradiņš University

Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond

Prof. Kitty Jager

Amsterdam University Medical Center, Netherlands

Assoc. Prof. Vianda Stel

Amsterdam University Medical Center, Netherlands

Prof. Alberto Ortiz

Autonomous University of Madrid, Spain

Assoc. Prof. Sabine Leh

University of Bergen, Norway

Scientific Committee

Oncology and Hematology – Biomarker-Driven Precision Medicine

• Prof. Arvīds Irmejs, Institute of Oncology and Molecular Genetics, Rīga Stradiņš University
• Prof. Zanda Daneberga, Institute of Oncology and Molecular Genetics, Rīga Stradiņš University
• Prof. Jānis Gardovskis, Department of Surgery, Faculty of Medicine, Rīga Stradiņš University
• Prof. Sandra Lejniece, Dean, Department of Doctoral Studies / Department of Internal Diseases, Rīga Stradiņš University
• Prof. Edvīns Miklaševičs, Faculty of Medicine, Department of Biology and Microbiology, Rīga Stradiņš University

Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond

• Prof. Alberto Ortiz, MD, PhD, Autonomous University of Madrid, Spain; Chief of Nephrology and Hypertension at Fundacion Jimenez Diaz University Hospital and Health Research Insitute (IIS-FJD UAM), Madrid, Spain 
• Prof. Kitty J. Jager, MD, PhD, Department of Medical Informatics at Amsterdam University Medical Center, Netherlands
• Assoc. Prof. and Principal Investigator Vianda S. Stel PhD, Department of Medical Informatics at Amsterdam University Medical Center, Netherlands; European Renal Association Registry Managing Director
• Assoc. Prof. Sabine Leh, MD, PhD, Department of Clinical Medicine, University of Bergen; Department of Pathology, Haukeland University Hospital; Registry pathologist, Norwegian Renal Registry.
• Prof. Aivars Pētersons, MD, PhD, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital
• Assoc. Prof. Viktorija Kuzema, MD, PhD, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital; Head of Latvian Kidney Replacement Therapy Patient Registry
• Assist. prof. Kristīne Oļeinika, PhD, Department of Internal Diseases, Rīga Stradiņš University; Postdoctoral Research Fellow, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA
• Assist. Prof. Kārlis Rācenis, MD, PhD, Department of Biology and Microbiology, Department of Internal Diseases, Rīga Stradiņš University; Nephrology Centre, Pauls Stradins Clinical University Hospital

Rare Diseases

• Assoc. Prof. Andris Skride, Rīga Stradiņš University
• Assoc. Prof. Madara Auzenbaha, Rīga Stradiņš University
• Dr. med. Linda Gailīte, Rīga Stradiņš University
• Assoc. Prof. Ainārs Rudzītis, Rīga Stradiņš University
• Prof. Aivars Lejnieks, Rīga Stradiņš University
• Dr. Valdis Ģībietis, Rīga Stradiņš University

Main Topics

Oncology and Hematology – Biomarker-Driven Precision Medicine

• Oncology
• Hematology
• Coagulation and Hemostasis 

Transforming Care: Treatment Quality Improvement in Kidney Disease and Beyond  

• IgA nephropathy 
• Immunology in renal diseases
• B cell immunity
• Surveillance of chronic kidney disease 
• Kidney disease registries
• Renal replacement therapy (hemodialysis, peritoneal dialysis, kidney transplantation) 
• Predialysis program

Rare Diseases

• Epidemiology and Natural History of Rare Diseases
• Diagnostic Challenges and Advances in Rare Diseases
• Innovative Therapies and Treatments for Rare Diseases
• Regulatory and Policy Issues in Rare Disease Research and Treatment
• Rare Disease Case Reports

Metabolism and Cardiovascular Diseases

26–27 March, Room 204, RSU, 21 Konsula iela

26 March. Arrhythmias, Cardiomyopathies, Invasive Cardiology, Cardiac Surgery

The session will address emerging therapies and current research in the field of cardiac arrhythmias, sports medicine, cardiomyopathies, interventional cardiology and cardiac surgery. Among the best selected abstracts there will be state-of-the-art lectures presented by local and international faculty.

27 March. Integrative Biomarker-Based Prevention of Cardiovascular and Metabolic Diseases, Personalized Therapy, and Identification of Drug Targets 

Biomedicine is recognized as one of the priorities for national research investments according to the Smart Specialization Strategy for Research and Innovation. For implementing this strategy an ambitious and unique project was carried out in 2023-2024 - State research project in the field of biomedicine, medical technologies and pharmacy.
The mission statement of this Project is:  improving access to treatment for reduction of mortality or morbidity rates and improved health conditions through the development of medicinal products and their manufacturing technologies, transport forms and vaccines, repurposing of marketed drugs, the drug discovery and development, as well as the identification of new biomarkers and the development of a precision medical solution
The implementation of the Project was performed in separate work packages (WP) by collaborative efforts of the consortium partners.  The WP2 "Integrative biomarker-based prevention of cardiovascular and metabolic diseases, personalized therapy, and identification of drug targets" aims to create new techniques and methods of personalized monitoring, diagnostic and treatment, aiming to promote implementation of the latest scientific discoveries and modern technologies into a clinical practice to improve survival and quality of life of Latvian population.

This project combine clinical medicine competencies of University of Latvia  (cardiovascular medicine) and Rīga Stradiņš University (metabolic diseases and neonatal medicine) with preclinical pharmacology expertise of the Latvian Institute of Organic Synthesis  and molecular biology research achievements of Latvian Biomedical Research and Study Centre.  
The following tasks were implemented during the  project: 

1. direct diagnostic accuracy comparison of intravascular ultrasound (IVUS), optical coherence tomography (OCT) and near infrared spectrometry (NIRS) for the detection and characterization of coronary plaque composition, including determination of atherosclerotic plaque rupture risk by positron emission tomography (PET/CT); 
2. evaluation of the expression of atherosclerosis related microRNAs and their correlation with unfavorable atherosclerotic plaque characteristics. 
3. evaluation of the effect of statins on acylcarnitine metabolism as a possible mechanism of statin associated myopathy (SAM); 
4. optimization of triple hormone administration to maximize weight loss, increase resting metabolic rate and to control blood glucose. 
5. search for new, sensitive prognostic biomarkers that can be implemented in clinical practice for the development of non-invasive testing algorithms for the early diagnosis, evaluation, and prognosis of life-threatening diseases in newborns. 
6. investigation of the opportunities to increase omega-3 PUFA content by inhibition of their metabolism; 
7. selection of anti-sense oligonucleotide candidates for the treatment of the calpainopathy. 

Today's conference is dedicated to the results of the above-mentioned research included in the WP2 package, their analysis and the perspective of further research.

(Integratīva biomarķieros balstīta kardiovaskulāro un metabolo slimību prevencija, personalizēta terapija un zāļu mērķu identificēšana) -  Ekonomikas ministrijas VPP-EM-BIOMEDICĪNA.  

Keynote Speakers

Prof. Aleš Linhart

Charles University in Prague, Czech Republic

Scientific Committee

• Prof. Aivars Lejnieks MD, PhD, Department of Internal Diseases, Riga Stradin’s University, Riga East University Hospital 
• Prof. Ilze Konrāde MD, PhD, Department of Internal Diseases, Riga Stradin’s University, Riga East University Hospital
• Maija Dambrova, Dr. pharm. Professor in the Department of Pharmaceutical Chemistry, Riga Stradins University; Head of Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis; Full Member of the Latvian Academy of Sciences
• Prof. Dace Gardovska MD, PhD, Department of Pediatrics, Riga Stradin’s University, Riga East University Hospital
• Prof. Oskars Kalējs, Rīga Stradiņš University
• Prof. Pēteris Stradiņš, Rīga Stradiņš University
• Dr. med. Mārtiņš Kalējs, Rīga Stradiņš University
• Assoc. Prof. Andris Skride, Rīga Stradiņš University
• Assoc. Prof. Ainārs Rudzītis, Rīga Stradiņš University
• Prof. Maija Radziņa, Rīga Stradiņš University
• Prof. Aleš Linhart, Charles University in Prague, Czech Republic
• Dr. med. Manuel Wilbring, Dresden University Hospital, Germany
• Prof. Andrejs Ērglis MD, PhD, Faculty of Medicine and Life Sciences, University of Latvia, Paula Stradin’s Clinical University Hospital 
• Vilnis Dzērve MD, PhD, Faculty of Medicine and Life Sciences, University of Latvia
• Osvalds Pugovics Dr. chem., Latvian Institute of Organic Synthesis
• Edgars Liepiņš, Dr. pharm., Principal Scientist at the Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis; Full Member of the Latvian Academy of Sciences

Main Topics

• Metabolism and cardiovascular diseases
• Arrhythmology
• Genetics in cardiology
• Cardiomyopathies
• Interventional cardiology
• Cardiac surgery

Sport Science, Sport Medicine and Rehabilitation

26–27 March, Auditorium #2, RSU, 16 Dzirciema iela

Keynote speakers

Prof. Jostein Hallén

Norwegian School of Sport Sciences

Prof. Susanna Hedenborg

Malmö University, Sweden

Prof. Bart Roelands

Vrije Universiteit Brussel, Belgium

Matteo Lancini

Mechanical and Thermal Measurement Laboratory of the University of Brescia, Italy

Prof. Yannis Pitsiladis

University of Brighton, United Kingdom

Assoc. Prof. Amelia Guadalupe Grau

University of Castilla-La Mancha, Spain

Prof. Fabio Pigozzi

University of Rome “Foro Italico”, Italy

Scientific Committee

• Prof. Inga Millere, Dean, Faculty of health and Sport Sciences, Rīga Stradiņš University, Latvia
• Prof. Aija Kļaviņa, Lead researcher, Rīga Stradiņš University, Latvia
• Assoc. Prof. Signe Tomsone, Department of Rehabilitation, Rīga Stradiņš University, Latvia
• Assoc. Prof. Kalvis Ciekurs, Latvian Academy of Sport Education, Riga Stradiņš University, Latvia
• Asst. Prof. Dace Reihmane, Lead researcher, Laboratory of Sports and Nutrition Research, Rīga Stradiņš University, Latvia
• Dr Sandra Rozenštoka, Lead Researcher, Institute of Public Health,  Rīga Stradiņš University, Latvia
• Prof. Bart Roelands, Human Physiology and Sports Physiotherapy Research Group, Vrije Universiteit, Belgium
• Prof. Susanna Hedenborg, Professor of Sports Science and Associate Professor in Social and Economic History, Malmo University, Sweden
• Prof. Yannis Pitsiladis, The Chairman of Scientific committee of the European Federation of Sports Medicine Associations, Professor of Sport and Exercise Science, University of Brighton, United Kingdom
• Prof. Matteo Lancini, Mechanical and Thermal Measurement Laboratory, University of Brescia, Italy 
• Assoc. Prof. Amelia Guadalupe-Grau, Universidad de Castilla-la Manch, Spain

Main Topics

• Sport science
• Sport medicine
• Rehabilitation

Women's and Children's Health

26–27 March, Auditorium #1, RSU, 16 Dzirciema iela

26 March. Empowering Women’s Health, Bridging Gaps, Advancing Care. Agenda

The main topics of the section Empowering Women’s Health, Bridging Gaps, Advancing Care are dedicated to the challenges of modern sexual and reproductive medicine, obstetrics, and gynecology. Together with world-renowned experts, we will discuss current issues in pregnancy termination, evidence-based obstetric practice, success in eradicating cervical cancer, the importance of the quality of sexual life in a woman's health, and advances in ultrasonography.

Agenda

Venue: Auditorium #1, RSU, 16 Dzirciema iela

Session I: Challenges of Sexual and Reproductive Health in the 21st Century in Latvia and Beyond Chair: Prof. Gunta Lazdāne (Latvia), Prof. Kristina Gemzell Danielsson (Sweden)
9:00–9:20	Sex Without Pain Gilbert Donders, Belgium
9:20–9:40	High Quality Abortion Care Kristina Gemzell Danielsson, Sweden
9:40–9:52	Understanding the Structure of Preterm Births in Latvia: A National Register-Based Study of Trends, Contributing Factors, and Public Health Implications Diāna Andžāne, Latvia
9:52–10:04	Evaluating Clinical Predictors of Pregnancy and Obstetric Outcomes in Singleton Pregnancies with Cervical Insufficiency Undergoing Cervical Cerclage and Expectant Treatment Valērija Rakša, Latvia
10:04–10:16	Pregnancy Outcomes in Kidney Transplant Recipients Ieva Ziediņa, Latvia
10:16–10:28	Biochemical Correlation Between Inhibin B and FSH in Spermatogenesis: Mechanisms, Pathways, and Regulatory Interactions Ecaterina Pavlocschi, Moldova
10:30–11:00	Break
Session II: Patient Experience as an Important Outcome Measure in Obstetrics Chair: Assoc. Prof. Anna Miskova (Latvia), Prof. Dace Rezeberga (Latvia)
11:00–11:15	Findings from the IMAgiNE EURO Study: Women’s Experiences of Respectful Maternity Care in Healthcare Facilities Across 22 Countries over 3.5 Years Marzia Lazzerini, Italy
11:15–11:22	Childbirth associated factors in quality of maternal care Elizabete Ārgale, Latvia
11:22–11:29	After-Birth Associated Factors in Quality of Maternal Care Barbara Baranovska, Poland
11:29–11:36	Birth Rights Associated Factors in Quality of Maternal Care Alina Liepinaitienė, Lithuania
11:36–11:43	Mental Health Related Factors in Quality of Maternal Care Valērija Rakša, Latvia
11:43–11:55	Childbirth Experience Among Primiparous Women in Latvia Undergoing Labor Induction: Insights from the Short Quality from Patient's Perspective-Intrapartal (s-QPP-I) Questionnaire Beāte Sārta, Latvia
11:55–12:07	Childbirth Experience Among Primiparas and Multiparas with Spontaneous Vaginal Delivery Irisa Zīle Velika, Latvia
12:07–12:30	Discussion
12:30–13:30	Break
Session III: Vulvovaginal Health – Best Practices and Emerging Trends Chair: Assoc. Prof. Jana Žodžika (Latvia), Prof. Gilbert Donders (Belgium)
13:30–13:50	Ingredients of Vulvovaginal Health Gilbert Donders, Belgium
13:50–14:02	Comparison of Vaginal Microflora Before and After Loop Electro-Excisional Procedure – Preliminary Results Laura Lūse, Latvia
14:02–14:14	The Associated Risk Factors Among Women Attending Colposcopy Clinic with High-Grade Squamous Intraepithelial Lesions and Above (HSIL+) Natalija Bērza, Latvia
14:14–14:26	Analysis of the Latvian Human Papillomavirus Type 16 Isolate Whole-Genome Sequencing Data from Cervical Carcinomas Within the Global Context of Publicly Available Complete HPV16 Genome Sequences Maria Isaguliants, Latvia
14:26–14:38	The Incidence and Types of Postoperative Complications of Simple, Radical Vulvectomies and Vulvectomies with Reconstruction Tsira Tolordava, Latvia
14:38–15:00	Discussion
15:00–15:30	Break
Session IV: The Involving Role of Ultrasound in Women's Health Chair: Prof. Natālija Vedmedovska (Latvia), Antonia Testa (Italy)
15:30–16:00	Diagnosis and Management of Ovarian Tumours During Pregnancy Antonia Testa, Italy
16:00–16:12	The Role of Ultrasound in the Preoperative Diagnosis of Ovarian Tumors During Pregnancy: A Case Report of Dysgerminoma Alise Vinogradova, Latvia
16:12–16:24	The Ophthalmic Artery – Is It Possible in Our Setting? Natālija Vedmedovska, Latvia
16:24–16:36	Routine Third Trimester Ultrasound Nowadays Ieva Evelīna Štolcere, Latvia
16:36–16:48	Vasa Praevia: A 10-Year Retrospective Analysis at Riga Maternity Hospital (2014–2024) Anna Ilva Sedliņa, Latvia
16:48–17:00	Placental Development in Spontaneous vs. Assisted Conception: Insights from 3D Ultrasound Imaging Diāna Bokučava, Latvia

Poster presentations

Venue: Cafeteria, RSU, 16 Dzirciema iela

10:30–11:00	Comparison of Spontaneous Singleton Labour and Induced Singleton Labour Elizabeta Lohova-Matīsa, Latvia
10:30–11:00	Analysis of the Incidence of Histologically Confirmed Chorioamnionitis in Preterm Deliveries Before 34 Weeks of Gestation at Rīga Maternity Hospital in 2023 Līva Ķīse, Latvia
12:30–13:30	Impact of Interventions During Labour on Women’s Perception of Childbirth Experience Evaluated by the Childbirth Experience Questionnaire Maija Priedniece, Latvia
12:30–13:30	A Case of Acheiria After Conception with Donor Oocytes Jūlija Tarasova, Latvia
12:30–13:30	Cervical Cancer Screening Patterns Among HIV-Positive Women in Latvia Elvita Penka, Latvia
12:30–13:30	Two Years of Human Papillomavirus (HPV) Screening in National Microbiology Reference Laboratory of Latvia: Achievements and Results Anastasija Ņiftaļijeva, Latvia
15:00–15:30	Müllerian Adenosarcoma: A Case Report Ivana Kumičikova, Slovakia
15:00–15:30	The First Eight Months of the Patient Contribution and Collaboration to the Oncology Research Through Informed Consent in Rīga East University Hospital Ināra Kampenuse, Latvia

10:30–11:00	Assessing Placental and Fetal Well-Being in Pregnancies Complicated by Umbilical Cord Abnormalities Through US imaging Techniques Milena Manic, Moldova
10:30–11:00	The Role of Umbilical Cord Pathology in Perinatal Outcomes in Term Deliveries Alina Alsatou, Moldova
12:30–13:30	Challenges in the Diagnosis of Placenta Precreta, Complicated with Rupture of the Uterus Mihaela Cospormac, Moldova
12:30–13:30	Ultrasonographic and Hysteroscopic Diagnosis of Adenomyosis: A Case Study Alexandra Chiricenco, Moldova
12:30–13:30	Clinical Insights into Agenesis of the Septum Pellucidum: A Case Report Natālija Vedmedovska, Latvia
12:30–13:30	A Case Report of Osteogenesis Imperfecta Type II-Rare Lethal Disorder Natālija Vedmedovska, Latvia
15:00–15:30	Approach to Transplacental Therapy of Pathological Fetal Tachycardias – Distinct Cases Natālija Vedmedovska, Latvia

27 March. Children and Infections – Forever Together, but the Dimension is Changing. Agenda

The comprehensive scientific programme of this section will give valuable insights into the latest advances of research and developments in paediatric infectious diseases combined with practice-changing updates in care of children with infections.

Participants of the section will have the opportunity to attend lectures given by leading researchers and practitioners in the pediatric infectious field. All the topics will be presented and discussed from multiple perspectives allowing each participant to gain knowledge. Results from extensive research of tick borne encephalitis (TBE) in Latvia as well as several EU Horizon 2020 projects which paved the way for the latest DIAMONDS project will be presented to demonstrate the long-term research process of developing a molecular test for the rapid diagnosis of serious infectious and inflammatory diseases using personalised gene signatures. Within the framework of these projects, findings from Emergency departments across Europe alongside national data from Latvia will be presented to bring research close to clinic. 

Furthermore, we encourage participants to share their research interests at the Poster section to interact with other colleagues, exchange ideas and foster new collaboration. We encourage to submit posters on the following topics:

• Paediatric infectious diseases
• Fever in children
• Tick borne encephalitis

You will have an opportunity to meet passionate researchers, network with colleagues with similar interests, gain cutting-edge knowledge with the ultimate and common aim to improve care for our children.

Agenda

Venue: Auditorium #1, RSU, 16 Dzirciema iela

Session I: Peadiatric Infectious Diseases – State-of-the-Art in the 21st Century Chair: Prof. Henriette Moll (Netherlands), Prof. Dace Zavadska (Latvia)
9:00–9:30	Viruses – only bad guys? Gerhard Dobler, Germany
9:30–10:00	Fever, Infectious Diseases and Diagnostic Approaches in the 21st Century Michael Levin, UK
10:30–11:00	Break
Session II: EU Horizon 2020 Projects PERFORM and DIAMONDS (2016–2025) Chair: Prof. Dace Gardovska (Latvia), Prof. Jana Pavāre (Latvia)
11:00–11:30	Personalised Molecular Signatures for Diagnosis of Infectious and Inflammatory Diseases: the PERFORM and DIAMONDS Results Myrsini Kaforou, UK
11:30–12:00	When is fever dangerous? The Role of New and Old Biomarkers at the Emergency Department Henriette Moll, The Netherlands
12:05–12:30	Upper Respiratory Tract / ENT and Flu-Like Infections in a Single Northern European Paediatric Emergency Department: a Comparative Study of 2017 and 2024 Flu Seasons Aleksandra Rudzāte, Latvia
12:30–13:30	Break
Session III: Tick-Borne Encephalitis Studies (2016–2025) Chair: Prof. Gerhard Dobler (Germany), Asst. Prof. Liene Čupāne (Latvia)
13:30–14:00	TBE in Latvia – Clinical Picture, Early and Long Term Sequelae Guntis Karelis, Latvia
14:00–14:30	TBE Prophylaxis – TBE Vaccine Effectiveness Studies Dace Zavadska, Latvia
14:30–15:00	Tick-Borne Encephalitis Vaccine Breakthroughs – New Insights in the Role of Antibodies in TBE Infection Gerhard Dobler, Germany
15:00–15:30	Break
Session IV: PhD Studies in Paediatric Infectious Diseases Chair: Prof. Dace Gardovska (Latvia), Prof. Inguna Lubaua (Latvia)
15:30–16:05	NS1 Antibody Research in Latvia and Its Clinical Relevance Zane Freimane, Latvia
16:05–16:30	Two-Year Outcomes of Multisystem Inflammatory Syndrome in Children (MIS-C): Findings from Tertiary Level Children’s Hospital Ieva Roģe-Gurecka, Latvia
16:30–16:55	Effect of Combination of Point-of-Care C-Reactive Protein Testing and Educational Training on Antibiotic Prescribing and Diagnostic Habits for Children Presenting with Acute Infections in General Practice Zane Līkopa, Latvia

Poster presentations

Venue: Cafeteria, RSU, 16 Dzirciema iela

10:40–10:50	Factors Affecting Metabolic Control of Type 1 Diabetes in Children One Year After Diagnosis Lizete Braivo, Latvia
10:50–11:00	Child-Centred Therapy Method Approach to Reduce Behavioural Signs in Children with Attention Deficit Hyperactivity Disorder: Systematic Literature Review Signe Ķezbere, Latvia
12:30–13:30	Prevalence of Purulent Complications of Acute Upper Respiratory Tract Infections Before and After COVID-19 Restrictions / Impact of the COVID-19 Pandemic on the Prevalence of Deep Throat Infections at the Children's Clinical University Hospital Estere Jansone, Latvia
12:30–13:30	The Effect of Dynamic Neuromuscular Stabilization on Muscle Activity in Palliative Care Children: A Study Protocol Laura Žalienė, Lithuania
12:30–13:30	Preliminary Data of Immune Modulator Assessment in Children with Long COVID-19 Annija Meiere, Latvia
12:30–13:30	Neonatal Urinary Metabolomics in Sepsis Dace Sniedze, Latvia
15:00–15:30	Evaluation of the Use of Platelet-Rich Fibrin Membrane for Myringoplasty in Paediatric Patients Ligita Kupica, Latvia
15:00–15:30	Minimally Invasive Diagnostic and Prognostic Biomarkers in Neonates with Necrotizing Enterocolitis: Case Series of Single Centre Experience Zane Ābola, Latvia

10:40–10:50	Bordetella Pertussis Outbreak in Latvia, 2024 Gaļina Muzje, Latvia
10:50–11:00	Adenoid Microbiota: Comparing Healthy and Otitis Media-Affected Middle Ears in Children Using 16S rRNA Sequencing Oļegs Sokolovs Karijs, Moldova
12:30–13:30	Seroprevalence of Tick-Borne Encephalitis in Latvia, 2019–2022, Indicates a High Disease Risk Zane Freimane, Latvia
12:30–13:30	Evaluation of Antibiotic Regimens for Non-Complicated Acute Appendicitis in Children Timurs Zurmutaī, Latvia
12:30–13:30	Cerebrovascular Manifestations of Lyme Neuroborreliosis in Paediatric Patients from 2014 to 2024: A Single Centre Experience Marija Luīze Kalniņa, Latvia
12:30–13:30	Acute Appendicitis in Paediatric Patients with SARS-CoV-2 Delta and Omicron Variants Timurs Zurmutaī, Latvia
15:00–15:30	Antibiotic Prescription Patterns for Children with Febrile Upper and Lower Respiratory Tract Infections in a Single Northern European Paediatric Emergency Department During Influenza Seasons 2017 and 2024 Evija Fusa, Latvia

Keynote Speakers

Prof. Gerhard Dobler

University of Hohenheim, Germany

Prof. Gilbert G.G. Donders

University of Antwerp, Belgium

Prof. Kristina Gemzell Danielsson

The Karolinska Institute, Sweden

Prof. Antonia Testa

Catholic University of Sacred Heart, Rome, Italy

Prof. Henriëtte Moll

Erasmus MC – Sophia Children’s Hospital, The Netherlands

Scientific Committee

Empowering Women’s Health, Bridging Gaps, Advancing Care

• Prof. Dace Rezeberga, Head Department of Obstetrics and Gynaecology, Rīga Stradiņš University
• Prof. Gunta Lazdāne, Department of Obstetrics and Gynaecology, Institute of Public Health, Rīga Stradiņš University
• Prof. Kristina Gemzell Danielsson, Karolinska Institutet, Sweden
• Prof. Natālija Vedmedovska, Department of Obstetrics and Gynaecology, Rīga Stradiņš University
• Assoc. Prof. Anna Miskova, Department of Obstetrics and Gynaecology, Rīga Stradiņš University
• Assoc. Prof. Jana Žodžika, Department of Obstetrics and Gynaecology, Institute of Public Health, Rīga Stradiņš University

Children and Infections - Forever Together, but the Dimension is Changing

• Prof. Gerhard Dobler, Bundeswehr Institute of Microbiology, German National Consultant Laboratory for TBEV, Munich, Germany; Dept. of Tropical Medicine and Infectious Diseases, Ludwig-Maximilians-Universität, Munich, Germany; Dept. of Parasitology, University of Hohenheim, Stuttgart, Germany
• Prof. Henriette Moll, Erasmus MC – Sophia Children’s Hospital, The Netherlands
• Prof. Dace Zavadska, Rīga Stradiņš University
• Prof. Jana Pavāre, Rīga Stradiņš University

Main Topics

Children's health 

• Children and infections 
  • Pediatric infectious diseases 
  • Fever in children 
• Pediatrics 
• Neonatology  

Women's health

• Sexual and reproductive health and rights
• Pregnancy and delivery care 
• Gynecology
• Ultrasound in obstetrics and gynecology
• Infertility
• Gynecological oncology and cancer prevention

Innovation in Medicine and Healthcare – from Research to Practice

26–27 March, Lobby, RSU, 21 Konsula iela

Rīga Stradiņš University Innovation section focuses on exploring Digital Transformation in Healthcare, showcasing advancements in Precision Medicine, Telemedicine  and Digital Innovations. The event gathers experts to discuss the latest in telemedicine, enhancing patient care through cutting-edge technology. Attendees gain insights into integrating digital tools to revolutionize healthcare delivery. Workshops and presentations emphasise the role of innovation in improving health outcomes and efficiency.

Keynote Speakers

Sigvards Krongorns

Verge HealthTech Fund

Baiba Ziemele

Latvian Network of Patient Organizations

Scientific Committee

• Assoc. Prof. Dins Šmits, Vice-Rector for Academic Affairs, Rīga Stradiņš University
• Lauris Vidzis, Chief Executive Officer, Pauls Stradins Clinical University Hospital 
• Baiba Ziemele, Chairman of the board Latvian, Network of Patient Organizations
• Antons Mislēvičs, Ph.D, Head of Artificial Intelligence and Machine Learning at C.t.co.

Main Topics

• Digital Transformation in Healthcare
• Precision medicine
• Digital innovations
• Telemedicine

Innovative Dosage Forms and Drug Delivery Systems

27 March, Room 305, RSU, 21 Konsula iela

Keynote Speakers

Henri Leinonen

School of Pharmacy, University of Eastern Finland

Scientific Committee

• Asst. Prof. Agnese Brangule, Department of Pharmaceutical Chemistry, Rīga Stradiņš University
• Konstantīns Logviss, Head of Laboratory of Finished Dosage Forms, Rīga Stradiņš University
• Assoc. Prof. Baiba Mauriņa, Vice-Dean, Faculty of Pharmacy, Rīga Stradiņš University
• Valentyn Mohylyuk, Leading visiting researcher, Faculty of Pharmacy, Rīga Stradiņš University
• Asst. Prof. Inga Urtāne, Head of Department of Pharmaceutical Chemistry, Rīga Stradiņš University
• Prof. Valdas Jakštas, Lithuanian University of Health Sciences (LSMU)

Main Topics

• Pharmaceutical Science
• Drug delivery systems 

Dental and Maxillofacial Sciences

 28 March, Room 305, RSU, 21 Konsula iela

Dental and Maxillofacial Sciences will focus on medical research, integrating cutting-edge technology and interdisciplinary approaches to improve patient care and outcomes in the oral and maxillofacial regions, innovations and translating scientific discoveries.

Keynote Speakers

Assoc. Prof. Linda Arvidsson

University of Oslo, Norway

Assoc. Prof. Ville Vuollo

University of Oulu, Finland

Scientific Committee

• Prof. Ilze Akota, Rīga Stradiņš University
• Prof. Ingrīda Čēma, Rīga Stradiņš University
• Assoc. Prof. Laura Neimane, Rīga Stradiņš University
• Assoc. Prof. Andris Ābeltiņš, Rīga Stradiņš University
• Asst. Prof. Ilze Šalma, Rīga Stradiņš University
• Prof. Ulvi Gursoy, Turku University, Finland

Main Topics

• Dentistry and related sciences
• Oral and Maxillofacial Surgery
• Biomaterials

Medical Diagnostics Evolution: From Morphology and Radiology to New Frontiers

28 March. From Past to Modern Morphology. Agenda

Date and Venue: 28 March, Room 204, RSU, 21 Konsula iela

The beauty of Histology reveals the inside of tissue and organs, but the other subdiscipline of Morphology – Anthropology displays the magnificence of body changes in external shape during the centuries. These subjects never persist separately but overlap with developmental Biology and Histopathology resulting in whole Morphology science. Thus, this section will focus on polymorphous Morphology including even an artificial intelligence and 3D printing aspects of nowadays subject.

Agenda

Session I Chair: Prof. Māra Pilmane
9:00–9:30	Advancing Neurological Disease Diagnostics: From Tissue Staining and Sequencing to AI-Assisted Language and Vision Models Zane Jaunmuktane, UK
9:30–10:00	Evaluation of sociocultural factor effects on general health status in Late Medieval to Early Modern Vilnius Inhabitants Rimantas Jankauskas, Lithuania
10:00–10:30	Can Anatomy Still Offer a Terra Incognita for Scientists? David Kachlik, Czechia
10:30–11:00	Break
Session II Chair: Prof. Māra Pilmane, Prof. Valērija Groma
11:00–11:30	Two Weeks Changes in Cytokines and Antimicrobial Proteins of Milk in Mastitis-Affected Free-Stall Barn Cows Māra Pilmane, Latvia
11:30–12:00	Appearance and Distribution of Voltage-Gated Sodium Channels in Excitable and Non-excitable Cells of the Human Brain Valērija Groma, Latvia
12:00–12:30	Anthropological Investigations of the Population of Latvia in the 21st Century Jānis Vētra, Latvia
12:30–13:30	Break
Session III Chair: Prof. Jānis Vētra
13:30–14:00	Multiform Morphology in the Digital Age: Evolution of Anatomical Studies with Virtual Dissection and 3D Printing Dzintra Kažoka, Latvia
14:00–14:20	Automatic Segmentation of Morphological Structures, Metastasis Detection, and 3D Model Reconstruction from Medical Imaging Utilizing Artificial Intelligence Based on Deep Neural Network Methodologies Edgars Edelmers, Latvia
14:20–14:40	Chronic Rhinosinusitis with Nasal Polyps in Latvia Rūdolfs Vīksne, Latvia
14:40–15:00	A Comparative Study of Acquired Cholesteatoma in Pediatric and Adult Populations Kristaps Dambergs, Latvia
15:00–15:30	Break
Session IV Chair: Prof. Ilze Štrumfa, Assoc. Prof. Liāna Pļaviņa
15:30–15:50	Aberrant Epithelial-Mesenchymal Transition in Parathyroid Pathology Romans Uļjanovs, Latvia
15:50–16:20	Elaboration of Morphological Model to Evaluate Long-Term Hepatobiliary Consequences of Covid-19 Ilze Štrumfa, Latvia
16:20–16:40	Evaluation of 12 Cleft Candidate Gene Proteins in Human Cleft Lip and Palate Tissue Mārtiņš Vaivads, Latvia
16:40–17:00	Identification of Distinct Osteoarthritis Subgroups via Cluster Analysis Sofija Semeņistaja, Latvia

Poster presentations

Venue: Cafeteria, RSU, 16 Dzirciema iela

10:30–11:00	The Evaluation of Human Beta Defensin-2, 3, 4 and Apoptosis in Placentas of Different Gestational Ages Anna Junga, Latvia
10:30–11:00	Characterization of Galactin (Gal-10) in Cleft Lip Palate (CLP) Affected Tissue Alise Elizabete Rone, Latvia
12:30–13:30	CDX1, SHH, IHH Genes and Their Protein’s Role in Ladd’s Band Development Evelīna Pivrika, Latvia
12:30–13:30	Anthropometric Analysis of Children Aged 1 to 15 Years in Piebalga, Latvia Arta Grabicka, Latvia
12:30–13:30	Analysis of Cephalic Index in Latvian Residents from Different Regions Based on 1930s Data Lāsma Asare, Latvia
12:30–13:30	The Association Between Body Mass Index, Blood Pressure and Resting Heart Rate in Adults from Piebalga, Latvia Līva Kuzmane, Latvia
15:00–15:30	Anthropometric Data Insights from Detailed Measurements in Piebalga, Latvia Arta Grabicka, Latvia

28 March. Radiological Patterns and Cognitive Function and  Radiology – From Pictures to Interventions and Beyond

Date and Venue: 28 March, Auditorium #1, RSU, 16 Dzirciema street

The section meeting will update information and research results on the development of an integrated approach to assessing cognitive abilities in patients with neurodegenerative diseases of the central nervous system, research and opportunities in interventional radiology, the development and application of artificial intelligence in neuroradiology, and current events and innovations in radiology

Keynote Speakers

From Past to Modern Morphology

David Kachlík

Charles University in Prague, Czech Republic

Zane Jaunmuktane

National Hospital for Neurology and Neurosurgery, UCLH NHS Foundation Trust, London, UK

Rimantas Jankauskas

Vilnius University, Lithuania

Radiological Patterns and Cognitive Function and  Radiology - from pictures to interventions and beyond

Prof. Baingio Pinna

Department of Biomedical Sciences, University of Sassari, Italy

Scientific Committee

From Past to Modern Morphology

• Prof. Māra Pilmane, Rīga Stradiņš University
• Andrejs Ivanovs, MD MSc PhD MRCP(UK) FRCPath, Department of Haematology, Edinburgh Cancer Centre, UK
• Asst. Prof. Anna Junga, Rīga Stradiņš University
• Assoc. Prof. Dzintra Kažoka, Rīga Stradiņš University

Radiological Patterns and Cognitive Function and  Radiology - from pictures to interventions and beyond

• Prof. Ardis Platkājis, Head of Department of Radiology, Rīga Stradiņš University
• Assoc. Prof. Maija Radziņa, Department of Radiology, Rīga Stradiņš University
• Asst. Prof. Nauris Zdanovskis, Department of Radiology, Rīga Stradiņš University
• Prof. Jurgis Sķilters, Chair of Laboratory for Perceptual and Cognitive Systems at the Faculty of Computing, University of Latvia

Main Topics

From past to modern Morphology

• Anthropology  
• Histology  
• Embryology and teratology  
• Histopathology 

Radiological Patterns and Cognitive Function 

• Imaging (Radiology) 
• Neuroimaging

Psychiatry

Date and Venue: 28 March, Auditorium #1, RSU, 16 Dzirciema iela

Agenda

Session I: Women's mental health in post-partum period Chair: Prof. Elmārs Rancāns, Asst. Prof. Ļubova Renemane
9:00–9:15	Assessment of Mental Health Service Utilization During the Peripartum Period in Riga Maternity Hospital and National Mental Health Centre: A 12-Month Overview Linda Rubene
9:15–9:30	Six-Month Findings on the Prevalence and Severity of Depressive Symptoms and Their Associations with Sociodemographic Characteristics in Postpartum Women Attending Outpatient Clinic Marija Lazareva
9:30–9:45	Eosinophilic Oesophagitis as an Underlying Cause of Patients Admitted with Food Bolus Obstruction under Otorhinolaryngologists in East of Scotland Marija Lazareva
9:45–10:00	Postpartum Anxiety and Sociodemographic Factors: Preliminary Results from a 6-Month Cross-Sectional Study in Latvia Silvija Cīpare
10:00–10:15	New postpartum mental health care model in Latvia: a qualitative evaluation by the postpartum women Elīna Zelčāne
10:15–10:30	The association between psychosocial factors and generalized anxiety symptoms in women during the first postpartum year Paula Kovaļevska
10:30–11:00	Break
Session II: Child and Youth Mental Health: focus on screening and interventions Chair: Asst. Prof. Ņikita Bezborodovs, Asst. Prof. Jeļena Koļesņikova
11:00–11:15	The Correlation Between Generalized Anxiety Symptoms and Adverse Childhood Experiences Among Pregnant Women in Latvia Lelde Logina
11:15–11:30	Recent advances in the development of screening instruments for early recognition of mental, behavioural and neurodevelopmental disorders in Latvian children and adolescents. Ņikita Bezborodovs
11:30–11:45	Bullying as a risk factor for Suicidal Behavior in Latvian adolescents: A Population-Based Study Marija Terēze Melzupe
11:45–12:00	Emotional and behavioural difficulties and Perception of Threat in Latvian adolescents: A population-based study Kristīne Kozlova
12:00–12:15	Internet-based Cognitive Behavioural Therapy for Adolescents and Young Adults with Depression and Anxiety: A Study Protocol for an Implementation Study Liene Dambiņa
12:15–12:30	Arts-Based Interventions Incorporating Myths for Adolescents: A Scoping Review Anita Bernāne
12:30–13:30	Break

Poster presentations

Venue: Cafeteria, RSU, 16 Dzirciema iela

10:40–11:00	Factors Influencing Depression Incidence in Latvian Family Medicine Doctors During Covid-19 Pandemic from January to March 2022 Lilija Ķēniņa
10:40–11:00	Practical Application of Sherborne Developmental Movement in Professional Practice: Insights from Practitioners in Latvia, the Netherlands, and the UK Diāna Semerova
12:30–13:00	The Correlation Between Anxiety and Depression Symptoms and Perceived Stress and Burnout in the Population of Latvian Radiographers and Radiology Assistants Laura Saulīte
12:30–13:00	Correlation between depression, anxiety and somatic symptoms among radiographers and radiology assistants in Latvia Marta Zande
12:30–13:00	Correlation between depression, anxiety symptoms, self-esteem, and different coping strategies among radiology assistants and radiographers in Latvia Marta Zande
10:40–11:00	Changes in scores of alexithymia before and after treatment in inpatient psychotherapeutic programme (Minnesota) in patients with substance use disorder Līva Mača
10:40–11:00	Clozapine Use in the Pediatric Population: Clinical Case Report and New Guidelines at Children’s Clinical University Hospital, Latvia Laura Ķevere
12:30–13:00	Correlation Between Depression, Anxiety Symptoms, and Self-Esteem Among Radiology Assistants and Radiographers in Latvia Lelde Smilte-Breča
12:30–13:00	The Correlation Between Depression, Anxiety Symptoms, and Work-Life Conflict Among Radiology Assistants and Radiographers Ilze Madara Brūvere
12:30–13:00	The Association Between Self-esteem, Relationship Satisfaction, and Work-life Conflict Among Radiology Assistants and Radiographers Ilze Madara Brūvere